Publications by authors named "Katty Wu"
Article Synopsis
- Cangrelor, an intravenous P2Y12-receptor inhibitor, is compared to traditional antithrombotic medications like eptifibatide in patients undergoing endovascular thrombectomies (EVTs), with previous data being insufficient for direct comparison.
- A study reviewed clinical data from 1010 EVT patients who received either cangrelor or eptifibatide to assess safety and efficacy, focusing on outcomes like hemorrhagic conversion and functional status using scales like the mRS and NIHSS.
- Results showed that cangrelor was linked to a lower risk of hemorrhagic conversion and better functional outcomes at discharge and follow-up, indicating its potential benefits over GPIs in this specific medical context
Background: Thrombectomy is now the standard of care in the treatment of acute ischemic stroke caused by emergent large vessel occlusion. Therefore thrombectomy services have expanded from Comprehensive Stroke Centers to Thrombectomy-Capable Stroke Centers. Stroke interventions at these sites are performed in both biplane and monoplane angiography suites.
View Article and Find Full Text PDFThe scarcely described phenomenon of acute ischaemic stroke due to bilateral large vessel occlusions and limited reports of its treatment raises the question about the best method for revascularisation. We present a simultaneous bilateral thrombectomy method on a patient with acute bilateral middle cerebral artery occlusions. This technique resulted in successful vessel recanalisation within 35 min without haemorrhagic complications-deeming the method both safe and effective.
View Article and Find Full Text PDF